These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 12421645)

  • 1. Comparison of the anticholinergic effects of the serotonergic antidepressants, paroxetine, fluvoxamine and clomipramine.
    Fujishiro J; Imanishi T; Onozawa K; Tsushima M
    Eur J Pharmacol; 2002 Nov; 454(2-3):183-8. PubMed ID: 12421645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of paroxetine on marble-burying behavior in mice.
    Shinomiya K; Fujii Y; Sugimoto Y; Azuma N; Tokunaga S; Kitazumi K; Kamei C
    Methods Find Exp Clin Pharmacol; 2005 Dec; 27(10):685-7. PubMed ID: 16395417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH; Goa KL
    CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacogenetics of the selective serotonin reuptake inhibitors.
    Brøsen K
    Clin Investig; 1993 Dec; 71(12):1002-9. PubMed ID: 8124052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder.
    Pigott TA; Seay SM
    J Clin Psychiatry; 1999 Feb; 60(2):101-6. PubMed ID: 10084636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective serotonin reuptake inhibitors fluvoxamine and paroxetine restore forced exercise-induced temperature dysregulation in ovariectomized mice.
    Ikeda M; Egawa T; Yamauchi A; Sohda Y; Koga A; Tominaga K; Shuto H; Kataoka Y
    Eur J Pharmacol; 2008 Jan; 579(1-3):439-44. PubMed ID: 18155696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paroxetine, sertraline, and fluvoxamine: new selective serotonin reuptake inhibitors.
    Grimsley SR; Jann MW
    Clin Pharm; 1992 Nov; 11(11):930-57. PubMed ID: 1464219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective serotonin reuptake inhibitors reduce the spontaneous activity of dopaminergic neurons in the ventral tegmental area.
    Di Mascio M; Di Giovanni G; Di Matteo V; Prisco S; Esposito E
    Brain Res Bull; 1998 Aug; 46(6):547-54. PubMed ID: 9744293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of alprazolam and desipramine hydroxylation in vitro by paroxetine and fluvoxamine: comparison with other selective serotonin reuptake inhibitor antidepressants.
    von Moltke LL; Greenblatt DJ; Court MH; Duan SX; Harmatz JS; Shader RI
    J Clin Psychopharmacol; 1995 Apr; 15(2):125-31. PubMed ID: 7782485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences between mice strains in response to paroxetine in the forced swimming test: involvement of serotonergic or noradrenergic systems.
    Sugimoto Y; Yamamoto M; Tagawa N; Kobayashi Y; Mitsui-Saitoh K; Hotta Y; Yamada J
    Eur J Pharmacol; 2011 Dec; 672(1-3):121-5. PubMed ID: 22004611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of the sigma1 receptor in inhibiting activity of fluvoxamine on marble-burying behavior: comparison with paroxetine.
    Egashira N; Harada S; Okuno R; Matsushita M; Nishimura R; Mishima K; Iwasaki K; Orito K; Fujiwara M
    Eur J Pharmacol; 2007 Jun; 563(1-3):149-54. PubMed ID: 17349995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluvoxamine: a selective serotonin re-uptake inhibitor for the treatment of obsessive-compulsive disorder.
    Dell'Osso B; Allen A; Hollander E
    Expert Opin Pharmacother; 2005 Dec; 6(15):2727-40. PubMed ID: 16316311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of chronic selective serotonin reuptake inhibitors on 8-OH-DPAT-induced facilitation of ejaculation in rats: comparison of fluvoxamine and paroxetine.
    de Jong TR; Pattij T; Veening JG; Waldinger MD; Cools AR; Olivier B
    Psychopharmacology (Berl); 2005 May; 179(2):509-15. PubMed ID: 15719219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of chronic treatment with fluvoxamine and paroxetine during adolescence on serotonin-related behavior in adult male rats.
    de Jong TR; Snaphaan LJ; Pattij T; Veening JG; Waldinger MD; Cools AR; Olivier B
    Eur Neuropsychopharmacol; 2006 Jan; 16(1):39-48. PubMed ID: 16107310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of peripheral inhibitory effects of clomipramine with selective serotonin re-uptake inhibitors on contraction of vas deferens: in vitro and in vivo studies.
    Seo KK; Kim SC; Lee MY
    J Urol; 2001 Jun; 165(6 Pt 1):2110-4. PubMed ID: 11371937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of REM sleep deprivation on cholinergic receptor sensitivity and passive avoidance behavior in clomipramine model of depression.
    Prathiba J; Kumar KB; Karanth KS
    Brain Res; 2000 Jun; 867(1-2):243-5. PubMed ID: 10837820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased sensitivity to antidepressants of D3 dopamine receptor-deficient mice in the forced swim test (FST).
    Leggio GM; Micale V; Drago F
    Eur Neuropsychopharmacol; 2008 Apr; 18(4):271-7. PubMed ID: 17804207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of interindividual variability and extent of CYP2D6 and CYP1A2 inhibition by paroxetine and fluvoxamine in vivo.
    Ozdemir V; Naranjo CA; Shulman RW; Herrmann N; Sellers EM; Reed K; Kalow W
    J Clin Psychopharmacol; 1998 Jun; 18(3):198-207. PubMed ID: 9617978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interaction of antidepressant drugs with central and peripheral (enteric) 5-HT3 and 5-HT4 receptors.
    Lucchelli A; Santagostino-Barbone MG; Barbieri A; Candura SM; Tonini M
    Br J Pharmacol; 1995 Mar; 114(5):1017-25. PubMed ID: 7780635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of the selective serotonin-reuptake inhibitors fluoxetine, paroxetine, citalopram and fluvoxamine in alcohol-preferring cAA rats.
    Maurel S; De Vry J; Schreiber R
    Alcohol; 1999 Apr; 17(3):195-201. PubMed ID: 10231167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.